Sustainability & Climate

Industry legend William Sheriff moves to Verdera Energy, unlocking a major New Mexico uranium portfolio in a strategic spin-out from giant enCore Energy.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

Norwegian Cruise Line reports strong 2025 earnings but a weak 2026 outlook, as its new CEO points to internal missteps and charts a course for recovery.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

A Chinese firm's 'Global Pioneer' status in cellular essence sparks debate on the future of biotech in cosmetics, medicine, and global regulation.

Experience the record-breaking Danjiang Bridge, Zaha Hadid's final work, with pre-opening events before its May 2026 debut. A new wonder rises in Taipei.

With new communities in Fayetteville and Collierville, SRI Management's strategic expansion signals a major move in the booming senior living market.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

The new Mesa II series promises 800°F searing and rapid assembly at a budget price. Can it redefine value or will durability concerns linger?

The Regina-based food giant aims to raise massive capital to pay down debt and accelerate its global expansion in the booming plant-based food market.

A $4.4 million inventory write-down plunges the world's first private cord blood bank into the red, raising questions about its public banking model.

The biotech firm's stock surged after announcing a massive share repurchase, a bold move balancing shareholder value with its high-stakes R&D pipeline.

With five influencer-designed Toyota Tacomas, a Japanese customizer plants its flag in the US, blending high-tech builds with community and conscience.

The acquisition of Canadian Food Safety Group signals a major strategic play to unify compliance training across the complex US and Canadian markets.

Korean skincare brand Purito Seoul unveils its 'From Soil to Seoul' vision, launching a global campaign with an immersive 'Oat Latte' pop-up in New York.

The kefir pioneer unveils a muscle-building drink and probiotic butter, leveraging strong financials to capture a share of the $75B cultured dairy boom.

First Nations pass a unanimous non-confidence motion against Alberta's government, citing a constitutional crisis over Treaty rights and separation rhetoric.

The Michael J. Fox Foundation adds private equity and AI venture capital leaders to its board, signaling a strategic push to accelerate a cure for Parkinson's.

As Cipla rolls out its affordable Liraglutide injection, the battle for the multi-billion dollar GLP-1 market intensifies, promising greater access for patients.